Guangzhou Wondfo Biotech Refuses to Lower Conversion Price of Convertible Bonds

Deep News10-21

On the evening of October 21, Guangzhou Wondfo Biotech Co., Ltd. announced that its fifth board meeting convened on October 21, 2025, where it reviewed and approved a proposal regarding the non-adjustment of the conversion price for its convertible bonds. The board decided not to lower the conversion price of the "Wondfo Convertible Bonds" and stated that from the next trading day after this decision, for the following three months (from October 22, 2025, to January 21, 2026), if the conditions for lowering the conversion price are triggered again, no proposal for such a downward adjustment will be made. Starting from January 22, 2026, if the conditions for lowering the conversion price are triggered again, the board will hold another meeting to decide whether to exercise the right to lower the conversion price of the "Wondfo Convertible Bonds".

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment